位置:首页 > 蛋白库 > ADA10_BOVIN
ADA10_BOVIN
ID   ADA10_BOVIN             Reviewed;         748 AA.
AC   Q10741; A8E663;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   03-AUG-2022, entry version 184.
DE   RecName: Full=Disintegrin and metalloproteinase domain-containing protein 10;
DE            Short=ADAM 10;
DE            EC=3.4.24.81 {ECO:0000250|UniProtKB:O14672};
DE   AltName: Full=Kuzbanian protein homolog;
DE   AltName: Full=Mammalian disintegrin-metalloprotease;
DE   AltName: Full=Myelin-associated metalloproteinase;
DE   AltName: CD_antigen=CD156c;
DE   Flags: Precursor;
GN   Name=ADAM10; Synonyms=MADM;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=8694785; DOI=10.1042/bj3170045;
RA   Howard L., Mitchell S., Lu X., Griffiths S., Glynn P.;
RT   "Molecular cloning of MADM: a catalytically active mammalian disintegrin-
RT   metalloprotease expressed in various cell types.";
RL   Biochem. J. 317:45-50(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 214-233, FUNCTION,
RP   SUBCELLULAR LOCATION, ACTIVE SITE, AND MUTAGENESIS OF GLU-384.
RX   PubMed=10097139; DOI=10.1073/pnas.96.7.3922;
RA   Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M.,
RA   Haass C., Fahrenholz F.;
RT   "Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid
RT   precursor protein by a disintegrin metalloprotease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:3922-3927(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Hereford; TISSUE=Basal ganglia;
RG   NIH - Mammalian Gene Collection (MGC) project;
RL   Submitted (SEP-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   MUTAGENESIS OF 210-ARG--ARG-213, SUBCELLULAR LOCATION, AND CLEAVAGE.
RX   PubMed=11481247; DOI=10.1096/fj.01-0007fje;
RA   Anders A., Gilbert S., Garten W., Postina R., Fahrenholz F.;
RT   "Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein
RT   convertases.";
RL   FASEB J. 15:1837-1839(2001).
RN   [5]
RP   INTERACTION WITH TSPAN5; TSPAN10; TSPAN14; TSPAN15; TSPAN17 AND TSPAN33.
RX   PubMed=23035126; DOI=10.1074/jbc.m112.416503;
RA   Haining E.J., Yang J., Bailey R.L., Khan K., Collier R., Tsai S.,
RA   Watson S.P., Frampton J., Garcia P., Tomlinson M.G.;
RT   "The TspanC8 subgroup of tetraspanins interacts with A disintegrin and
RT   metalloprotease 10 (ADAM10) and regulates its maturation and cell surface
RT   expression.";
RL   J. Biol. Chem. 287:39753-39765(2012).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 455-646, DISULFIDE BONDS, SUBUNIT,
RP   AND MUTAGENESIS OF GLU-573; GLU-578 AND GLU-579.
RX   PubMed=16239146; DOI=10.1016/j.cell.2005.08.014;
RA   Janes P.W., Saha N., Barton W.A., Kolev M.V., Wimmer-Kleikamp S.H.,
RA   Nievergall E., Blobel C.P., Himanen J.P., Lackmann M., Nikolov D.B.;
RT   "Adam meets Eph: an ADAM substrate recognition module acts as a molecular
RT   switch for ephrin cleavage in trans.";
RL   Cell 123:291-304(2005).
RN   [7] {ECO:0007744|PDB:5L0Q}
RP   X-RAY CRYSTALLOGRAPHY (2.76 ANGSTROMS) OF 455-646, GLYCOSYLATION AT
RP   ASN-551, AND DISULFIDE BONDS.
RX   PubMed=27503072; DOI=10.1084/jem.20151095;
RA   Atapattu L., Saha N., Chheang C., Eissman M.F., Xu K., Vail M.E., Hii L.,
RA   Llerena C., Liu Z., Horvay K., Abud H.E., Kusebauch U., Moritz R.L.,
RA   Ding B.S., Cao Z., Rafii S., Ernst M., Scott A.M., Nikolov D.B.,
RA   Lackmann M., Janes P.W.;
RT   "An activated form of ADAM10 is tumor selective and regulates cancer stem-
RT   like cells and tumor growth.";
RL   J. Exp. Med. 213:1741-1757(2016).
CC   -!- FUNCTION: Cleaves the membrane-bound precursor of TNF-alpha to its
CC       mature soluble form. Responsible for the proteolytical release of
CC       soluble JAM3 from endothelial cells surface (By similarity).
CC       Responsible for the proteolytic release of several other cell-surface
CC       proteins, including heparin-binding epidermal growth-like factor,
CC       ephrin-A2, CD44, CDH2 and for constitutive and regulated alpha-
CC       secretase cleavage of amyloid precursor protein (APP)
CC       (PubMed:10097139). Contributes to the normal cleavage of the cellular
CC       prion protein (By similarity). Involved in the cleavage of the adhesion
CC       molecule L1 at the cell surface and in released membrane vesicles,
CC       suggesting a vesicle-based protease activity (By similarity). Controls
CC       also the proteolytic processing of Notch and mediates lateral
CC       inhibition during neurogenesis (By similarity). Responsible for the
CC       FasL ectodomain shedding and for the generation of the remnant ADAM10-
CC       processed FasL (FasL APL) transmembrane form (By similarity). Also
CC       cleaves the ectodomain of the integral membrane proteins CORIN and
CC       ITM2B (By similarity). Mediates the proteolytic cleavage of LAG3,
CC       leading to release the secreted form of LAG3 (By similarity). Mediates
CC       the proteolytic cleavage of IL6R and IL11RA, leading to the release of
CC       secreted forms of IL6R and IL11RA (By similarity). Enhances the
CC       cleavage of CHL1 by BACE1 (By similarity). Cleaves NRCAM (By
CC       similarity). Cleaves TREM2, resulting in shedding of the TREM2
CC       ectodomain (By similarity). Involved in the development and maturation
CC       of glomerular and coronary vasculature (By similarity). During
CC       development of the cochlear organ of Corti, promotes pillar cell
CC       separation by forming a ternary complex with CADH1 and EPHA4 and
CC       cleaving CADH1 at adherens junctions (By similarity). May regulate the
CC       EFNA5-EPHA3 signaling (By similarity). {ECO:0000250|UniProtKB:O14672,
CC       ECO:0000250|UniProtKB:O35598, ECO:0000269|PubMed:10097139}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Endopeptidase of broad specificity.; EC=3.4.24.81;
CC         Evidence={ECO:0000250|UniProtKB:O14672};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:O14672};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250|UniProtKB:O14672};
CC   -!- ACTIVITY REGULATION: Catalytically inactive when the propeptide is
CC       intact and associated with the mature enzyme (PubMed:11481247). The
CC       disintegrin and cysteine-rich regions modulate access of substrates to
CC       exerts an inhibitory effect on the cleavage of ADAM10 substrates (By
CC       similarity). {ECO:0000250|UniProtKB:O14672,
CC       ECO:0000269|PubMed:11481247}.
CC   -!- SUBUNIT: Forms a ternary EFNA5-EPHA3-ADAM10 complex mediating EFNA5
CC       extracellular domain shedding by ADAM10 which regulates the EFNA5-EPHA3
CC       complex internalization and function (PubMed:16239146). Interacts with
CC       the clathrin adapter AP2 complex subunits AP2A1, AP2A2, AP2B1, and
CC       AP2M1; this interaction facilitates ADAM10 endocytosis from the plasma
CC       membrane during long-term potentiation in hippocampal neurons (By
CC       similarity). Interacts with EPHA2 (By similarity). Interacts (via
CC       extracellular domain) with TSPAN33 (via extracellular domain) and (via
CC       cytoplasmic domain) with AFDN; interaction with TSPAN33 allows the
CC       docking of ADAM10 to zonula adherens through a PDZ11-dependent
CC       interaction between TSPAN33 and PLEKHA7 while interaction with AFDN
CC       locks ADAM10 at zonula adherens (By similarity). Forms a ternary
CC       complex composed of ADAM10, EPHA4 and CADH1; within the complex, ADAM10
CC       cleaves CADH1 which disrupts adherens junctions (By similarity).
CC       Interacts with NGF in a divalent cation-dependent manner (By
CC       similarity). Interacts with TSPAN14; the interaction promotes ADAM10
CC       maturation and cell surface expression (PubMed:23035126). Interacts
CC       with TSPAN5, TSPAN10, TSPAN15, TSPAN17 and TSPAN33; these interactions
CC       regulate ADAM10 substrate specificity (PubMed:23035126). Interacts with
CC       DLG1; this interaction recruits ADAM10 to the cell membrane during
CC       long-term depression in hippocampal neurons (By similarity). Interacts
CC       (via extracellular domain) with BACE1 (via extracellular domain) (By
CC       similarity). Interacts with FAM171A1 (By similarity).
CC       {ECO:0000250|UniProtKB:O14672, ECO:0000250|UniProtKB:O35598,
CC       ECO:0000269|PubMed:16239146, ECO:0000269|PubMed:23035126}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane
CC       {ECO:0000269|PubMed:10097139}; Single-pass type I membrane protein
CC       {ECO:0000305}. Cell membrane {ECO:0000269|PubMed:10097139,
CC       ECO:0000269|PubMed:11481247}; Single-pass type I membrane protein
CC       {ECO:0000305}. Cytoplasmic vesicle, clathrin-coated vesicle
CC       {ECO:0000250|UniProtKB:O14672}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:O35598}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:O35598}. Cell junction, adherens junction
CC       {ECO:0000250|UniProtKB:O14672}. Cytoplasm
CC       {ECO:0000250|UniProtKB:O14672}. Note=Is localized in the plasma
CC       membrane but is also expressed in the Golgi apparatus and in clathrin-
CC       coated vesicles derived likely from the Golgi (By similarity). During
CC       long term depression, it is recruited to the cell membrane by DLG1 (By
CC       similarity). The immature form is mainly located near cytoplasmic
CC       fibrillar structures, while the mature form is predominantly located at
CC       zonula adherens and the cell membrane (By similarity). The localization
CC       and clustering of mature ADAM10 to zonula adherens is regulated by
CC       AFDN, TSPAN33, PLEKHA7 and PDZD11 (By similarity).
CC       {ECO:0000250|UniProtKB:O14672, ECO:0000250|UniProtKB:O35598}.
CC   -!- TISSUE SPECIFICITY: Expressed at low level in kidney, spleen, lung,
CC       adrenal, heart and peripheral nerve.
CC   -!- INDUCTION: By interleukin-1 alpha in nasal cartilage.
CC   -!- DOMAIN: The Cys-rich region C-terminal to the disintegrin domain
CC       functions as a substrate-recognition module, it recognizes the EFNA5-
CC       EPHA3 Complex but not the individual proteins PubMed:16239146. Both
CC       Cys-rich and stalk region are necessary for interaction with TSPAN5,
CC       TSPAN10, TSPAN14, TSPAN17, TSPAN33 (By similarity). Stalk region is
CC       sufficient for interaction with TSPAN15 (By similarity).
CC       {ECO:0000250|UniProtKB:O35598, ECO:0000269|PubMed:16239146}.
CC   -!- DOMAIN: The propeptide keeps the metalloprotease in a latent form via a
CC       cysteine switch mechanism. This mechanism may be mediated by a highly
CC       conserved cysteine (Cys-173) in the propeptide, which interacts and
CC       neutralizes the zinc-coordinating HEXGHXXGXXHD catalytic core of the
CC       metalloprotease domain. The dissociation of the cysteine from the zinc
CC       ion upon the activation-peptide release activates the enzyme.
CC       {ECO:0000250|UniProtKB:P03956}.
CC   -!- PTM: The precursor is cleaved by furin and PCSK7.
CC       {ECO:0000269|PubMed:11481247}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z21961; CAA79973.1; -; mRNA.
DR   EMBL; BC153863; AAI53864.1; -; mRNA.
DR   PIR; S66129; S66129.
DR   RefSeq; NP_776921.1; NM_174496.2.
DR   PDB; 2AO7; X-ray; 2.90 A; A=455-646.
DR   PDB; 5L0Q; X-ray; 2.76 A; A/D=455-646.
DR   PDBsum; 2AO7; -.
DR   PDBsum; 5L0Q; -.
DR   AlphaFoldDB; Q10741; -.
DR   SMR; Q10741; -.
DR   DIP; DIP-48422N; -.
DR   IntAct; Q10741; 5.
DR   STRING; 9913.ENSBTAP00000042110; -.
DR   MEROPS; M12.210; -.
DR   PaxDb; Q10741; -.
DR   PeptideAtlas; Q10741; -.
DR   PRIDE; Q10741; -.
DR   ABCD; Q10741; 1 sequenced antibody.
DR   Ensembl; ENSBTAT00000075105; ENSBTAP00000056919; ENSBTAG00000005481.
DR   GeneID; 282132; -.
DR   KEGG; bta:282132; -.
DR   CTD; 102; -.
DR   VEuPathDB; HostDB:ENSBTAG00000005481; -.
DR   VGNC; VGNC:25604; ADAM10.
DR   eggNOG; KOG3658; Eukaryota.
DR   GeneTree; ENSGT00940000160579; -.
DR   HOGENOM; CLU_004602_0_0_1; -.
DR   InParanoid; Q10741; -.
DR   OMA; GICERYK; -.
DR   OrthoDB; 162519at2759; -.
DR   TreeFam; TF352021; -.
DR   EvolutionaryTrace; Q10741; -.
DR   Proteomes; UP000009136; Chromosome 10.
DR   Bgee; ENSBTAG00000005481; Expressed in conceptus and 111 other tissues.
DR   ExpressionAtlas; Q10741; baseline and differential.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0005794; C:Golgi apparatus; ISS:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005798; C:Golgi-associated vesicle; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0097038; C:perinuclear endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0046930; C:pore complex; IEA:Ensembl.
DR   GO; GO:0014069; C:postsynaptic density; IEA:Ensembl.
DR   GO; GO:0097060; C:synaptic membrane; IBA:GO_Central.
DR   GO; GO:0097197; C:tetraspanin-enriched microdomain; IEA:Ensembl.
DR   GO; GO:0004175; F:endopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0070573; F:metallodipeptidase activity; IEA:Ensembl.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IDA:ARUK-UCL.
DR   GO; GO:1902945; F:metalloendopeptidase activity involved in amyloid precursor protein catabolic process; IDA:ARUK-UCL.
DR   GO; GO:0008237; F:metallopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; ISS:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0034332; P:adherens junction organization; IEA:Ensembl.
DR   GO; GO:0042987; P:amyloid precursor protein catabolic process; IDA:ARUK-UCL.
DR   GO; GO:0090102; P:cochlea development; IEA:Ensembl.
DR   GO; GO:0051089; P:constitutive protein ectodomain proteolysis; IEA:Ensembl.
DR   GO; GO:0038004; P:epidermal growth factor receptor ligand maturation; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; ISS:UniProtKB.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; ISS:UniProtKB.
DR   GO; GO:0042117; P:monocyte activation; IEA:Ensembl.
DR   GO; GO:0007162; P:negative regulation of cell adhesion; ISS:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0007219; P:Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0046931; P:pore complex assembly; IEA:Ensembl.
DR   GO; GO:0030307; P:positive regulation of cell growth; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0010820; P:positive regulation of T cell chemotaxis; IEA:Ensembl.
DR   GO; GO:0099173; P:postsynapse organization; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0016485; P:protein processing; IDA:ARUK-UCL.
DR   GO; GO:0098696; P:regulation of neurotransmitter receptor localization to postsynaptic specialization membrane; IEA:Ensembl.
DR   GO; GO:0008593; P:regulation of Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:1901342; P:regulation of vasculature development; IEA:Ensembl.
DR   GO; GO:0034612; P:response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:1901998; P:toxin transport; IEA:Ensembl.
DR   CDD; cd04270; ZnMc_TACE_like; 1.
DR   Gene3D; 3.40.390.10; -; 1.
DR   Gene3D; 4.10.70.10; -; 1.
DR   InterPro; IPR034025; ADAM10_ADAM17.
DR   InterPro; IPR027053; ADAM_10.
DR   InterPro; IPR001762; Disintegrin_dom.
DR   InterPro; IPR036436; Disintegrin_dom_sf.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR001590; Peptidase_M12B.
DR   InterPro; IPR002870; Peptidase_M12B_N.
DR   PANTHER; PTHR45702:SF4; PTHR45702:SF4; 1.
DR   Pfam; PF00200; Disintegrin; 1.
DR   Pfam; PF01562; Pep_M12B_propep; 1.
DR   SMART; SM00050; DISIN; 1.
DR   SUPFAM; SSF57552; SSF57552; 1.
DR   PROSITE; PS50215; ADAM_MEPRO; 1.
DR   PROSITE; PS50214; DISINTEGRIN_2; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Cell projection;
KW   Cleavage on pair of basic residues; Cytoplasm; Cytoplasmic vesicle;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Golgi apparatus;
KW   Hydrolase; Membrane; Metal-binding; Metalloprotease;
KW   Notch signaling pathway; Phosphoprotein; Protease; Reference proteome;
KW   SH3-binding; Signal; Transmembrane; Transmembrane helix; Zinc; Zymogen.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   PROPEP          20..213
FT                   /evidence="ECO:0000269|PubMed:10097139,
FT                   ECO:0000269|PubMed:11481247"
FT                   /id="PRO_0000029064"
FT   CHAIN           214..748
FT                   /note="Disintegrin and metalloproteinase domain-containing
FT                   protein 10"
FT                   /id="PRO_0000029065"
FT   TOPO_DOM        20..672
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        673..696
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        697..748
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          220..456
FT                   /note="Peptidase M12B"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00276"
FT   DOMAIN          457..551
FT                   /note="Disintegrin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00068"
FT   REGION          704..748
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          734..748
FT                   /note="Interaction with AP2A1, AP2A2 and AP2M1"
FT                   /evidence="ECO:0000250|UniProtKB:O35598"
FT   MOTIF           171..178
FT                   /note="Cysteine switch"
FT   MOTIF           708..715
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           722..728
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        706..722
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        384
FT                   /evidence="ECO:0000269|PubMed:10097139"
FT   BINDING         173
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /note="in inhibited form"
FT                   /evidence="ECO:0000250|UniProtKB:P03956"
FT   BINDING         383
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   BINDING         387
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   BINDING         393
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   SITE            213..214
FT                   /note="Cleavage; by furin and PCSK7"
FT                   /evidence="ECO:0000269|PubMed:11481247"
FT   MOD_RES         719
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   CARBOHYD        267
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        278
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        439
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        551
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0007744|PDB:5L0Q"
FT   DISULFID        344..451
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        399..435
FT                   /evidence="ECO:0000250|UniProtKB:O14672"
FT   DISULFID        460..495
FT                   /evidence="ECO:0000269|PubMed:27503072,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        471..484
FT                   /evidence="ECO:0000269|PubMed:27503072,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        473..479
FT                   /evidence="ECO:0000269|PubMed:27503072,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        483..515
FT                   /evidence="ECO:0000269|PubMed:27503072,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        503..511
FT                   /evidence="ECO:0000269|PubMed:16239146,
FT                   ECO:0000269|PubMed:27503072, ECO:0007744|PDB:2AO7,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        510..536
FT                   /evidence="ECO:0000269|PubMed:16239146,
FT                   ECO:0000269|PubMed:27503072, ECO:0007744|PDB:2AO7,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        524..543
FT                   /evidence="ECO:0000269|PubMed:16239146,
FT                   ECO:0000269|PubMed:27503072, ECO:0007744|PDB:2AO7,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        530..562
FT                   /evidence="ECO:0000269|PubMed:16239146,
FT                   ECO:0000269|PubMed:27503072, ECO:0007744|PDB:2AO7,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        555..567
FT                   /evidence="ECO:0000269|PubMed:16239146,
FT                   ECO:0000269|PubMed:27503072, ECO:0007744|PDB:2AO7,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        572..598
FT                   /evidence="ECO:0000269|PubMed:16239146,
FT                   ECO:0000269|PubMed:27503072, ECO:0007744|PDB:2AO7,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        580..607
FT                   /evidence="ECO:0000269|PubMed:16239146,
FT                   ECO:0000269|PubMed:27503072, ECO:0007744|PDB:2AO7,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        582..597
FT                   /evidence="ECO:0000269|PubMed:16239146,
FT                   ECO:0000269|PubMed:27503072, ECO:0007744|PDB:2AO7,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        594..639
FT                   /evidence="ECO:0000269|PubMed:16239146,
FT                   ECO:0000269|PubMed:27503072, ECO:0007744|PDB:2AO7,
FT                   ECO:0007744|PDB:5L0Q"
FT   DISULFID        632..645
FT                   /evidence="ECO:0000269|PubMed:16239146,
FT                   ECO:0000269|PubMed:27503072, ECO:0007744|PDB:2AO7,
FT                   ECO:0007744|PDB:5L0Q"
FT   MUTAGEN         210..213
FT                   /note="RKKR->NAQA: Abolishes furin cleavage site, leading
FT                   to defects in pro."
FT                   /evidence="ECO:0000269|PubMed:11481247"
FT   MUTAGEN         384
FT                   /note="E->A: Decreased stimulated and constitutive
FT                   secretion of APP."
FT                   /evidence="ECO:0000269|PubMed:10097139"
FT   MUTAGEN         573
FT                   /note="E->A: Abrogates EFNA5 cleavage; when associated with
FT                   Ala-578 and 579."
FT                   /evidence="ECO:0000269|PubMed:16239146"
FT   MUTAGEN         578
FT                   /note="E->A: Abrogates EFNA5 cleavage; when associated with
FT                   Ala-573 and 579."
FT                   /evidence="ECO:0000269|PubMed:16239146"
FT   MUTAGEN         579
FT                   /note="E->A: Abrogates EFNA5 cleavage; when associated with
FT                   Ala-573 and 578."
FT                   /evidence="ECO:0000269|PubMed:16239146"
FT   TURN            476..478
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   STRAND          482..484
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   STRAND          487..489
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   TURN            505..507
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   STRAND          523..525
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   STRAND          529..531
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   TURN            556..559
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   STRAND          563..566
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   HELIX           571..574
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   STRAND          578..580
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   HELIX           591..594
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   STRAND          597..600
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   HELIX           604..606
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   HELIX           616..619
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   TURN            633..636
FT                   /evidence="ECO:0007829|PDB:5L0Q"
FT   STRAND          637..639
FT                   /evidence="ECO:0007829|PDB:5L0Q"
SQ   SEQUENCE   748 AA;  84188 MW;  202E29830611F9E1 CRC64;
     MVLLRVLILL LSWVAGLGGQ YGNPLNKYIR HYEGLSYDVD SLHQKHQRAK RAVSHEDQFL
     RLDFHAHGRH FNLRMKRDTS LFSEEFRVET SNAVLDYDTS HIYTGHIYGE EGSFSHGSVI
     DGRFEGFIQT HGGTFYVEPA ERYIKDRTLP FHSVIYHEDD IKYPHKYGPQ GGCADHSVFE
     RMRKYQMTGV EEVTQTPQEK HAINGPELLR KKRTTVAEKN TCQLYIQTDH LFFKYYGTRE
     AVIAQISSHV KAIDTIYQTT DFSGIRNISF MVKRIRINTT ADEKDPTNPF RFPNIGVEKF
     LELNSEQNHD DYCLAYVFTD RDFDDGVLGL AWVGAPSGSS GGICEKSKLY SDGKKKSLNT
     GIITVQNYGS HVPPKVSHIT FAHEVGHNFG SPHDSGTECT PGESKNLGQK ENGNYIMYAR
     ATSGDKLNNN KFSLCSIRNI SQVLEKKRNN CFVESGQPIC GNGMVEQGEE CDCGYSDQCK
     DECCYDANQP EGKKCKLKPG KQCSPSQGPC CTAHCAFKSK TEKCRDDSDC AKEGICNGIT
     ALCPASDPKP NFTDCNRHTQ VCINGQCAGS ICEKHGLEEC TCASSDGKDD KELCHVCCMK
     KMEPSTCAST GSVQWNKYFL GRTITLQPGS PCNDFRGYCD VFMRCRLVDA DGPLARLKKA
     IFSPELYENI AEWIVAYWWA VLLMGIALIM LMAGFIKICS VHTPSSNPKL PPPKPLPGTL
     KRRRPPQPIQ QPQRQRPRES YQMGHMRR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024